Learning Objectives:
1. To understand how donor clonal hematopoiesis impacts recipient outcomes, including relapse, graft-versus-host disease, and donor cell leukemia.
2. To learn about the factors that determine molecular persistence in remission.
3. To gain an appreciation of how recipient germline mutations influence allogeneic transplantation outcomes
Session date:
02/28/2022 - 12:00pm to 1:00pm CST
Location:
Virtually
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Coleman Lindsley, MD, PhD